-
Molbio Diagnosti
1,393.10 925.80(%) -
Pine Labs
206.10 283.70(%) -
Larsen & Toubro
3,880.55 3,288.65(%) -
HDFC Bank
708.90 1,020.35(%) -
Power Grid Corpn
268.30 250.05(%) -
ESDS Software
1,716.35 1,716.35(%) -
Trent
2,815.00 3,497.35(%) -
Raymond
1,024.00 1,024.00(%) -
Metro Brands
924.20 883.40(%) -
Reliance Industries
1,253.20 1,250.55(%) -
Billionbrains
200.90 227.00(%) -
Ather Energy
1,615.00 530.65(%) -
One 97
1,829.50 1,829.50(%) -
Hind.Aeronautics
4,861.65 3,479.20(%) -
UPL
567.25 558.00(%) -
HDFC Life Insur.
531.15 796.60(%) -
Bajaj Finance
1,015.40 788.40(%) -
Lodha Developers
1,076.00 650.85(%) -
Dhoot Transmission
1,727.35 1,727.35(%) -
Britannia Inds.
4,946.05 4,946.05(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Kwality Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln
- Indian Private
- BSE Code : 68403.0
- ISIN : INE552U01010
-
Today’s Low
3,422.30 -
Today’s High
3,694.00
-
Open
3,500.10 -
Perv Close
3,511.60 -
52W Low
1,561.00 -
52W High
3,798.90
Key Indicators
-
P/E(TTM)
46.30
-
Mar.Cap (₹Cr.)
3,780.36
-
Div & Yield %
0.00
-
Book Value(₹)
320.51
-
Debt-Equity Ratio
3.75
-
AGM Date
11-Sep-2026
-
EPS
78.68
-
P/E Ratio
46.30
Financials Ratios
-
Debt-Equity Ratio
0.45
-
Mar.Cap (₹Cr.)
3,780.36
-
RONW (%)
13.66
-
ROCE (%)
15.86
Score Board
-
Equity (₹ in Cr.)
10.38
-
BV (₹)
320.50
-
Sales( ₹ in Cr.)
503.06
-
NP (in Cr.)
67.43
-
NP Var(%)
69.0
-
Div%
0.0
-
CPS (₹)
84.10
-
EPS (₹)
65.00
-
Traded Value (₹ in Lakhs)
3,779.53
-
52 Week High
3,798.90
-
52 Week Low
1,561.00
-
Price BSE
3643.0
-
Price NSE
3,643.00
-
Market Capital( in Cr.)
3,779.53
-
P/C Ratio
43.30
-
P/E Ratio
56.10
-
Price Vs.BV
65.00
-
03-Sep-2026( 12:40)
Corporate News - Kwali... - <p>Kwality Pharmaceuticals Lim...
-
10-Aug-2026( 02:43)
Results - Announcements - Kwali... - Kwality Pharmaceuticals Ltd sh...
-
08-Aug-2026( 09:53)
Corporate News - Kwali... - Kwality Pharmaceuticals Limite...
-
24-Jul-2026( 11:10)
Corporate News - Kwali... - Kwality Pharmaceuticals has ac...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)| Particulars(INCOME) | 2026 Mar | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar |
|---|---|---|---|---|---|---|
| INCOME : | ||||||
| Sales Turnover | 503.06 | 370.20 | 307.17 | 250.99 | 456.13 | 261.50 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 503.06 | 370.20 | 307.17 | 250.99 | 456.13 | 261.50 |
| Other Income | 2.86 | 1.92 | 1.83 | 2.94 | 3.51 | 1.59 |
| Stock Adjustments | -0.28 | -1.17 | 1.48 | 3.20 | 2.51 | -0.09 |
| Total Income | 505.64 | 370.95 | 310.48 | 257.13 | 462.15 | 263.00 |
| EXPENDITURE : | ||||||
| Raw Materials | 258.16 | 181.31 | 154.66 | 113.27 | 203.11 | 165.50 |
| Power and Fuel Cost | 26.69 | 23.37 | 17.22 | 12.96 | 11.06 | 6.11 |
| Employee Cost | 51.10 | 41.24 | 30.43 | 28.10 | 18.74 | 14.48 |
| Other Manufacturing Expenses | 2.96 | 3.32 | 6.75 | 4.98 | 4.57 | 3.78 |
| Selling and Administration Expenses | 44.42 | 37.31 | 30.74 | 32.57 | 48.71 | 41.12 |
| Miscellaneous Expenses | 2.05 | 2.03 | 9.32 | 17.97 | 0.72 | 1.16 |
| Employee Benefit Expenses | 51.10 | 41.24 | 30.43 | 28.10 | 18.74 | 14.48 |
| Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Expenses | 385.39 | 288.58 | 249.12 | 209.85 | 286.91 | 232.14 |
| Operating Profit | 120.26 | 82.37 | 61.37 | 47.29 | 175.24 | 30.86 |
| Interest | 10.97 | 9.88 | 10.39 | 6.61 | 2.92 | 2.62 |
| Gross Profit | 109.29 | 72.49 | 50.98 | 40.68 | 172.32 | 28.24 |
| Depreciation | 19.79 | 18.26 | 19.51 | 14.92 | 10.64 | 6.44 |
| Profit Before Tax | 89.50 | 54.23 | 31.47 | 25.76 | 161.68 | 21.80 |
| Current Tax | 23.03 | 15.93 | 7.92 | 6.16 | 41.35 | 6.22 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.89 | -1.59 | -0.44 | 0.14 | 0.27 | 0.16 |
| Reported Net Profit | 67.35 | 39.89 | 23.98 | 19.47 | 120.05 | 15.42 |
| Extraordinary Items | -0.09 | 0.04 | -5.31 | -12.24 | 0.00 | -0.01 |
| Adjusted Net Profit | 67.44 | 39.85 | 29.29 | 31.71 | 120.05 | 15.43 |
| Adjustment below Net Profit | 0.18 | 0.01 | -0.06 | 0.00 | 0.08 | 0.00 |
| P & L Balance brought forward | 246.20 | 206.30 | 182.38 | 162.91 | 42.78 | 27.37 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| P & L Balance carried down | 313.73 | 246.20 | 206.30 | 182.38 | 162.91 | 42.78 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Per Share(Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings Per Share-Unit Curr | 64.90 | 38.44 | 23.11 | 18.76 | 115.69 | 14.86 |
| Earnings Per Share(Adj)-Unit Curr | 64.90 | 38.44 | 23.11 | 18.76 | 115.69 | 14.86 |
| Book Value | 320.51 | 255.43 | 216.98 | 193.93 | 175.17 | 59.47 |
| Book Value(Adj)-Unit Curr | 320.51 | 255.43 | 216.98 | 193.93 | 175.17 | 59.47 |
